{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T11:27:26Z","timestamp":1743334046174},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00105-020-04739-4","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T16:02:56Z","timestamp":1608307376000},"page":"106-113","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pr\u00e4vention HPV-induzierter Erkrankungen durch prophylaktische Impfung","Prevention of HPV-induced diseases by prophylactic vaccination"],"prefix":"10.1007","volume":"72","author":[{"given":"Ulrike","family":"Wieland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"4739_CR1","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","volume":"346","author":"H Ali","year":"2013","unstructured":"Ali\u00a0H, Donovan\u00a0B, Wand\u00a0H et\u00a0al (2013) Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 346:f2032","journal-title":"BMJ"},{"key":"4739_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009069.pub3","author":"M Arbyn","year":"2018","unstructured":"Arbyn\u00a0M, Xu\u00a0L, Simoens\u00a0C et\u00a0al (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009069.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"4739_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.meegid.2013.03.011","volume":"18","author":"HU Bernard","year":"2013","unstructured":"Bernard\u00a0HU (2013) Taxonomy and phylogeny of papillomaviruses: an overview and recent developments. Infect Genet Evol 18:357\u2013361","journal-title":"Infect Genet Evol"},{"key":"4739_CR4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard\u00a0V, Baan\u00a0R, Straif\u00a0K et\u00a0al (2009) A review of human carcinogens\u2014Part B: biological agents. Lancet Oncol 10:321\u2013322","journal-title":"Lancet Oncol"},{"issue":"5","key":"4739_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/CCO.0000000000000211","volume":"27","author":"JM Brotherton","year":"2015","unstructured":"Brotherton\u00a0JM, Ogilvie\u00a0GS (2015) Current status of human papillomavirus vaccination. Curr Opin Oncol 27(5):399\u2013404","journal-title":"Curr Opin Oncol"},{"issue":"48","key":"4739_CR6","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1016\/j.vaccine.2015.06.088","volume":"33","author":"X Castellsague","year":"2015","unstructured":"Castellsague\u00a0X, Giuliano\u00a0AR, Goldstone\u00a0S et al (2015) Immunogenicity and safety of the 9\u2011valent HPV vaccine in men. Vaccine 33(48):6892\u20136901","journal-title":"Vaccine"},{"issue":"3","key":"4739_CR7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268815002198","volume":"144","author":"PE Castle","year":"2016","unstructured":"Castle\u00a0PE, Maza\u00a0M (2016) Prophylactic HPV vaccination: past, present, and future. Epidemiol Infect 144(3):449\u2013468","journal-title":"Epidemiol Infect"},{"issue":"11","key":"4739_CR8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","volume":"41","author":"HW Chesson","year":"2014","unstructured":"Chesson\u00a0HW, Dunne\u00a0EF, Hariri\u00a0S, Markowitz\u00a0LE (2014) The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis 41(11):660\u2013664","journal-title":"Sex Transm Dis"},{"issue":"9","key":"4739_CR9","doi-asserted-by":"crossref","first-page":"e13590","DOI":"10.1111\/ctr.13590","volume":"33","author":"PV Chin-Hong","year":"2019","unstructured":"Chin-Hong\u00a0PV, Reid\u00a0GE (2019) Human papillomavirus infection in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33(9):e13590","journal-title":"Clin Transplant"},{"key":"4739_CR10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2014-051813","volume":"91","author":"EP Chow","year":"2015","unstructured":"Chow\u00a0EP, Read\u00a0TR, Wigan\u00a0R et\u00a0al (2015) Ongoing decline in genital warts among young heterosexuals 7\u00a0years after the Australian human papillomavirus (HPV) vaccination programme. Sex Transm Infect 91:214\u2013219","journal-title":"Sex Transm Infect"},{"issue":"11","key":"4739_CR11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose\u00a0S, Quint\u00a0WG, Alemany\u00a0L et al (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a\u00a0retrospective cross-sectional worldwide study. Lancet Oncol 11(11):1048\u20131056","journal-title":"Lancet Oncol"},{"issue":"2","key":"4739_CR12","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel\u00a0C, Georges\u00a0D, Bray\u00a0F et\u00a0al (2020) Global burden of cancer attributable to infections in 2018: a\u00a0worldwide incidence analysis. Lancet Glob Health 8(2):e180\u2013e190","journal-title":"Lancet Glob Health"},{"issue":"7","key":"4739_CR13","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H De Vuyst","year":"2009","unstructured":"De Vuyst\u00a0H, Clifford\u00a0GM, Nascimento\u00a0MC et al (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a\u00a0meta-analysis. Int J Cancer 124(7):1626\u20131636","journal-title":"Int J Cancer"},{"issue":"20","key":"4739_CR14","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2017.04.001","volume":"35","author":"JP Dhar","year":"2017","unstructured":"Dhar\u00a0JP, Essenmacher\u00a0L, Dhar\u00a0R et\u00a0al (2017) The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus. Vaccine 35(20):2642\u20132646","journal-title":"Vaccine"},{"issue":"5","key":"4739_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","volume":"15","author":"M Drolet","year":"2015","unstructured":"Drolet\u00a0M, Benard\u00a0E, Boily\u00a0MC et al (2015) Population-level impact and herd effects following human papillomavirus vaccination programmes: a\u00a0systematic review and meta-analysis. Lancet Infect Dis 15(5):565\u2013580","journal-title":"Lancet Infect Dis"},{"key":"4739_CR16","unstructured":"Epidemiologisches Bulletin 10 (2020) Gesetz f\u00fcr den Schutz vor Masern und zur St\u00e4rkung der Impfpr\u00e4vention. (https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2020\/Ausgaben\/10_20.pdf?__blob=publicationFile). Zugegriffen: 23.\u00a0Nov. 2020"},{"key":"4739_CR17","unstructured":"Epidemiologisches Bulletin 32\/33 (2020) Impfstatus der Kinder und Jugendlichen in Deutschland. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2020\/Ausgaben\/32-33_20.pdf?__blob=publicationFile. Zugegriffen: 23.\u00a0Nov. 2020"},{"key":"4739_CR18","unstructured":"Epidemiologisches Bulletin 34 (2020) Empfehlungen der St\u00e4ndigen Impfkommission beim Robert Koch-Institut 2020\/2021. (https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2020\/Ausgaben\/34_20.pdf?__blob=publicationFile)"},{"key":"4739_CR19","unstructured":"European AIDS Clinical Society (2020) EACS Guidelines, Version 10.1. https:\/\/www.eacsociety.org\/files\/2019_guidelines-10.0_final.pdf. Zugegriffen: 23.\u00a0Nov. 2020"},{"issue":"7","key":"4739_CR20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/0961203316672928","volume":"26","author":"C Feldman","year":"2017","unstructured":"Feldman\u00a0C, Liu\u00a0J, Feldman\u00a0S et al (2017) Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs. Lupus 26(7):682\u2013689","journal-title":"Lupus"},{"issue":"6","key":"4739_CR21","doi-asserted-by":"crossref","first-page":"e20163947","DOI":"10.1542\/peds.2016-3947","volume":"140","author":"DG Ferris","year":"2017","unstructured":"Ferris\u00a0DG, Samakoses\u00a0R, Block\u00a0SL et al (2017) 4\u2011Valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents after 10 years. Pediatrics 140(6):e20163947","journal-title":"Pediatrics"},{"issue":"2","key":"4739_CR22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.autrev.2018.09.001","volume":"18","author":"M Garc\u00eda-Carrasco","year":"2019","unstructured":"Garc\u00eda-Carrasco\u00a0M, Mendoza-Pinto\u00a0C, Rojas-Villarraga\u00a0A et al (2019) Prevalence of cervical HPV infection in women with systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev 18(2):184\u2013191","journal-title":"Autoimmun Rev"},{"issue":"9769","key":"4739_CR23","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","volume":"377","author":"AR Giuliano","year":"2011","unstructured":"Giuliano\u00a0AR, Lee\u00a0JH, Fulp\u00a0W et\u00a0al (2011) Incidence and clearance of genital human papillomavirus infection in men (HIM): a\u00a0cohort study. Lancet 377(9769):932\u2013940","journal-title":"Lancet"},{"issue":"5","key":"4739_CR24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano\u00a0AR, Palefsky\u00a0JM, Goldstone\u00a0S et\u00a0al (2011) Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N\u00a0Engl J Med 364(5):401\u2013411","journal-title":"N Engl J Med"},{"issue":"15","key":"4739_CR25","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/cncr.29992","volume":"122","author":"T Guo","year":"2016","unstructured":"Guo\u00a0T, Eisele\u00a0DW, Fakhry\u00a0C et\u00a0al (2016) The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer 122(15):2313\u20132323","journal-title":"Cancer"},{"issue":"12","key":"4739_CR26","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1172\/JCI57149","volume":"121","author":"PE Gravitt","year":"2011","unstructured":"Gravitt\u00a0PE (2011) The known unknowns of HPV natural history. J\u00a0Clinical Invest 121(12):4593\u20134599","journal-title":"J Clinical Invest"},{"issue":"35\u201336","key":"4739_CR27","first-page":"586","volume":"115","author":"T Gredner","year":"2018","unstructured":"Gredner\u00a0T, Behrens\u00a0G, Stock\u00a0C et\u00a0al (2018) Cancers due to infection and selected environmental factors. Dtsch Arztebl Int 115(35\u201336):586\u2013593","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"4739_CR28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00430-003-0181-2","volume":"193","author":"G Gross","year":"2004","unstructured":"Gross\u00a0G, Pfister\u00a0H (2004) Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 193(1):35\u201344","journal-title":"Med Microbiol Immunol"},{"issue":"2","key":"4739_CR29","first-page":"242","volume":"16","author":"GE Gross","year":"2018","unstructured":"Gross\u00a0GE, Werner\u00a0RN, Becker\u00a0JC et al (2018) S2k guideline: HPV-associated lesions of the external genital region and the anus\u2014anogenital warts and precancerous lesions of the vulva, the penis, and the peri- and intra-anal skin (short version). J\u00a0Dtsch Dermatol Ges 16(2):242\u2013255","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9581","key":"4739_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich\u00a0AE, van Leeuwen\u00a0MT, Falster\u00a0MO, Vajdic\u00a0CM (2007) Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a\u00a0meta-analysis. Lancet 370(9581):59\u201367","journal-title":"Lancet"},{"issue":"12","key":"4739_CR31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13027-017-0129-6","volume":"11","author":"S Hartwig","year":"2017","unstructured":"Hartwig\u00a0S, St. Guily\u00a0JL, Dominiak-Felden\u00a0LG et al (2017) Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9\u2011valent HPV vaccine types in women and men in Europe. Infect Agent Cancer 11(12):19","journal-title":"Infect Agent Cancer"},{"key":"4739_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pvr.2017.05.002","volume":"4","author":"L Haeggblom","year":"2017","unstructured":"Haeggblom\u00a0L, Ramqvist\u00a0T, Tommasino\u00a0M et al (2017) Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3\u00a0years. Papillomavirus Res 4:1\u201311","journal-title":"Papillomavirus Res"},{"issue":"12","key":"4739_CR33","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/ijc.30035","volume":"138","author":"E Herweijer","year":"2016","unstructured":"Herweijer\u00a0E, Sundstrom\u00a0K, Ploner\u00a0A et al (2016) Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: a population-based study. Int J Cancer 138(12):2867\u20132874","journal-title":"Int J Cancer"},{"issue":"7","key":"4739_CR34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","volume":"298","author":"A Hildesheim","year":"2007","unstructured":"Hildesheim\u00a0A, Herrero\u00a0R, Wacholder\u00a0S et\u00a0al (2007) Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a\u00a0randomized trial. JAMA 298(7):743\u2013753","journal-title":"JAMA"},{"issue":"22","key":"4739_CR35","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2016.17615","volume":"316","author":"OE Iversen","year":"2016","unstructured":"Iversen\u00a0OE, Miranda\u00a0MJ, Ulied\u00a0A et al (2016) Immunogenicity of the 9\u2011valent HPV vaccine using 2\u2011dose regimens in girls and boys vs a\u00a03-dose regimen in women. JAMA 316(22):2411\u20132421","journal-title":"JAMA"},{"issue":"8","key":"4739_CR36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"EA Joura","year":"2015","unstructured":"Joura\u00a0EA, Giuliano\u00a0AR, Iversen\u00a0OE et al (2015) A 9\u2011valent HPV vaccine against infection and intraepithelial neoplasia in women. N\u00a0Engl J Med 372(8):711\u2013723","journal-title":"N Engl J Med"},{"issue":"3","key":"4739_CR37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/cid\/cix797","volume":"66","author":"SK Kjaer","year":"2018","unstructured":"Kjaer\u00a0SK, Nyg\u00e5rd\u00a0M, Dillner\u00a0J et al (2018) A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 nordic countries. Clin Infect Dis 66(3):339\u2013345","journal-title":"Clin Infect Dis"},{"key":"4739_CR38","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jmv.23318","volume":"84","author":"KF Komlos","year":"2012","unstructured":"Komlos\u00a0KF, Kocjan\u00a0BJ, Kosorok\u00a0P et al (2012) Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a\u00a0study on 574 tissue specimens. J\u00a0Med Virol 84:1233\u20131241","journal-title":"J Med Virol"},{"key":"4739_CR39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1471-2334-10-360","volume":"10","author":"AA Kraut","year":"2010","unstructured":"Kraut\u00a0AA, Schink\u00a0T, Schulze-Rath\u00a0R et al (2010) Incidence of anogenital warts in Germany: a\u00a0population-based cohort study. BMC Infect Dis 10:360","journal-title":"BMC Infect Dis"},{"issue":"7","key":"4739_CR40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1470-2045(15)00047-9","volume":"16","author":"AR Kreimer","year":"2015","unstructured":"Kreimer\u00a0AR, Struyf\u00a0F, Del Rosario-Raymundo\u00a0MR et al (2015) Efficacy of fewer than three doses of an HPV-16\/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. Lancet Oncol 16(7):775\u2013786","journal-title":"Lancet Oncol"},{"issue":"6","key":"4739_CR41","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2133.2010.09712.x","volume":"162","author":"A Kreuter","year":"2010","unstructured":"Kreuter\u00a0A, Potthoff\u00a0A, Brockmeyer\u00a0NH et al (2010) Anal carcinoma in human immunodeficiency virus-positive men: results of a\u00a0prospective study from Germany. Br J Dermatol 162(6):1269\u20131277","journal-title":"Br J Dermatol"},{"issue":"9","key":"4739_CR42","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","volume":"13","author":"D Kumar","year":"2013","unstructured":"Kumar\u00a0D, Unger\u00a0ER, Panicker\u00a0G et\u00a0al (2013) Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant 13(9):2411\u20132417","journal-title":"Am J Transplant"},{"issue":"14","key":"4739_CR43","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"383","author":"J Lei","year":"2020","unstructured":"Lei\u00a0J, Ploner\u00a0A, Elfstr\u00f6m\u00a0KM et\u00a0al (2020) HPV vaccination and the risk of invasive cervical cancer. N\u00a0Engl J Med 383(14):1340\u20131348","journal-title":"N Engl J Med"},{"issue":"2","key":"4739_CR44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","volume":"18","author":"C Lin","year":"2018","unstructured":"Lin\u00a0C, Franceschi\u00a0S, Clifford\u00a0GM (2018) Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a\u00a0systematic review and meta-analysis. Lancet Infect Dis 18(2):198\u2013206","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"4739_CR45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz\u00a0N, Bosch\u00a0FX, de Sanjos\u00e9\u00a0S et\u00a0al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N\u00a0Engl J Med 348(6):518\u2013527","journal-title":"N Engl J Med"},{"issue":"8","key":"4739_CR46","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4161\/hv.29532","volume":"10","author":"PS Naud","year":"2014","unstructured":"Naud\u00a0PS, Roteli-Martins\u00a0CM, De Carvalho\u00a0NS et al (2014) Sustained efficacy, immunogenicity, and safety of the HPV-16\/18 AS04-adjuvanted vaccine: final analysis of a\u00a0long-term follow-up study up to 9.4\u00a0years post-vaccination. Hum Vaccin Immunother 10(8):2147\u20132162","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"4739_CR47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","volume":"15","author":"C Ndiaye","year":"2014","unstructured":"Ndiaye\u00a0C, Mena\u00a0M, Alemany\u00a0L et al (2014) HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a\u00a0systematic review and meta-analysis. Lancet Oncol 15(12):1319\u20131331","journal-title":"Lancet Oncol"},{"issue":"5","key":"4739_CR48","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2215\/CJN.09690915","volume":"11","author":"DR Nelson","year":"2016","unstructured":"Nelson\u00a0DR, Neu\u00a0AM, Abraham\u00a0A et\u00a0al (2016) Immunogenicity of human papillomavirus recombinant vaccine in children with CKD. Clin J Am Soc Nephrol 11(5):776\u2013784","journal-title":"Clin J Am Soc Nephrol"},{"key":"4739_CR49","first-page":"17","volume":"3","author":"U Oberle","year":"2018","unstructured":"Oberle\u00a0U, Keller-Stanislawski\u00a0B (2018) Sicherheit der Impfung gegen humane Papillomviren (HPV). Bull Arzneimittelsicherh 3:17\u201323","journal-title":"Bull Arzneimittelsicherh"},{"issue":"1","key":"4739_CR50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","volume":"20","author":"TB Olesen","year":"2019","unstructured":"Olesen\u00a0TB, Sand\u00a0FL, Rasmussen\u00a0CL et\u00a0al (2019) Prevalence of human papillomavirus DNA and p16INK4a\u00a0in penile cancer and penile intraepithelial neoplasia: a\u00a0systematic review and meta-analysis. Lancet Oncol 20(1):145\u2013158","journal-title":"Lancet Oncol"},{"issue":"10","key":"4739_CR51","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.pvr.2020.100203","volume":"11","author":"SE Olsson","year":"2020","unstructured":"Olsson\u00a0SE, Restrepo\u00a0JA, Reina\u00a0JC et al (2020) Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15\u00a0years of age: Interim analysis after 8\u00a0years of follow-up. Papillomavirus Res 11(10):100203","journal-title":"Papillomavirus Res"},{"key":"4739_CR52","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2019.12.016","volume":"38","author":"M Orumaa","year":"2020","unstructured":"Orumaa\u00a0M, Kjaer\u00a0SK, Dehlendorff\u00a0C et al (2020) The impact of HPV multi-cohort vaccination: real-world evidence of faster control of HPV-related morbidity. Vaccine 38:1345\u20131351","journal-title":"Vaccine"},{"issue":"17","key":"4739_CR53","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky\u00a0JM, Giuliano\u00a0AR, Goldstone\u00a0S et\u00a0al (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N\u00a0Engl J Med 365(17):1576\u20131585","journal-title":"N Engl J Med"},{"key":"4739_CR54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-13-39","volume":"13","author":"H Patel","year":"2013","unstructured":"Patel\u00a0H, Wagner\u00a0M, Singhal\u00a0P et\u00a0al (2013) Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 13:39","journal-title":"BMC Infect Dis"},{"key":"4739_CR55","unstructured":"Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e.\u202fV. (2019) Krebs in Deutschland f\u00fcr 2015\/2016. 12. Ausgabe. https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/kid_2019\/krebs_in_deutschland_2019.pdf?__blob=publicationFile. Zugegriffen: 23. Nov. 2020"},{"issue":"1773","key":"4739_CR56","doi-asserted-by":"crossref","first-page":"20180289","DOI":"10.1098\/rstb.2018.0289","volume":"374","author":"S Roberts","year":"2019","unstructured":"Roberts\u00a0S, Evans\u00a0D, Mehanna\u00a0H, Parish\u00a0JL (2019) Modelling human papillomavirus biology in oropharyngeal keratinocytes. Philos Trans R Soc Lond B Biol Sci 374(1773):20180289","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"8","key":"4739_CR57","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/ijc.31883","volume":"144","author":"FL Sand","year":"2019","unstructured":"Sand\u00a0FL, Munk\u00a0C, Frederiksen\u00a0K et\u00a0al (2019) Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types. Int J Cancer 144(8):1975\u20131982","journal-title":"Int J Cancer"},{"issue":"9590","key":"4739_CR58","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman\u00a0M, Castle\u00a0PE, Jeronimo\u00a0J, Rodriguez\u00a0AC, Wacholder\u00a0S (2007) Human papillomavirus and cervical cancer. Lancet 370(9590):890\u2013907","journal-title":"Lancet"},{"issue":"Suppl 5","key":"4739_CR59","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","volume":"30","author":"JT Schiller","year":"2012","unstructured":"Schiller\u00a0JT, Castellsague\u00a0X, Garland\u00a0SM (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30(Suppl 5):F123\u2013F138","journal-title":"Vaccine"},{"issue":"10","key":"4739_CR60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrmicro2872","volume":"10","author":"JT Schiller","year":"2012","unstructured":"Schiller\u00a0JT, Lowy\u00a0DR (2012) Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol 10(10):681\u2013692","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"4739_CR61","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S1470-2045(14)71179-9","volume":"16","author":"JT Schiller","year":"2015","unstructured":"Schiller\u00a0JT, M\u00fcller\u00a0M (2015) Next generation prophylactic human papillomavirus vaccines. Lancet Oncol 16(5):e217\u2013e225","journal-title":"Lancet Oncol"},{"issue":"32 Pt A","key":"4739_CR62","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/j.vaccine.2017.12.079","volume":"36","author":"J Schiller","year":"2018","unstructured":"Schiller\u00a0J, Lowy\u00a0D (2018) Explanations for the high potency of HPV prophylactic vaccines. Vaccine 36(32 Pt A):4768\u20134773","journal-title":"Vaccine"},{"issue":"1","key":"4739_CR63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/1471-0528.13070","volume":"122","author":"T Schwarz","year":"2015","unstructured":"Schwarz\u00a0T, Spaczynski\u00a0M, Kaufmann\u00a0A et al (2015) Persistence of immune responses to the HPV-16\/18 AS04-adjuvanted vaccine in women aged 15\u201355\u00a0years and first-time modelling of antibody responses in mature women: results from an open-label 6\u2011year follow-up study. BJOG 122(1):107\u2013118","journal-title":"BJOG"},{"key":"4739_CR64","doi-asserted-by":"publisher","unstructured":"Segal\u00a0JP, Askari\u00a0A, Clark\u00a0SK, Hart\u00a0AL, Faiz\u00a0OD (2020) The Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD. Inflamm Bowel Dis. https:\/\/doi.org\/10.1093\/ibd\/izaa035. Epub ahead of print. PMID: 32080713","DOI":"10.1093\/ibd\/izaa035"},{"issue":"33","key":"4739_CR65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","volume":"68","author":"V Senkomago","year":"2019","unstructured":"Senkomago\u00a0V, Henley\u00a0SJ, Thomas\u00a0CC et al (2019) Human papillomavirus-attributable cancers\u2014United States, 2012\u20132016. MMWR Morb Mortal Wkly Rep 68(33):724\u2013728","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"2","key":"4739_CR66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2010.01.024","volume":"117","author":"M Stanley","year":"2010","unstructured":"Stanley\u00a0M (2010) Pathology and epidemiology of HPV infection in females. Gynecol Oncol 117(2):5\u201310","journal-title":"Gynecol Oncol"},{"issue":"7","key":"4739_CR67","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/cid\/cir1036","volume":"54","author":"KA Swedish","year":"2012","unstructured":"Swedish\u00a0KA, Factor\u00a0SH, Goldstone\u00a0SE (2012) Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a\u00a0nonconcurrent cohort study. Clin Infect Dis 54(7):891\u2013898","journal-title":"Clin Infect Dis"},{"key":"4739_CR68","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2147\/IDR.S178381","volume":"12","author":"ZQ Toh","year":"2019","unstructured":"Toh\u00a0ZQ, Kosasih\u00a0J, Russell\u00a0FM et\u00a0al (2019) Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus. Infect Drug Resist 12:1951\u20131967","journal-title":"Infect Drug Resist"},{"key":"4739_CR69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ypmed.2011.08.017","volume":"53","author":"JE Tota","year":"2011","unstructured":"Tota\u00a0JE, Chevarie-Davis\u00a0M, Richardson\u00a0LA, de Vries\u00a0M, Franco\u00a0EL (2011) Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Prev Med 53:12\u201321","journal-title":"Prev Med"},{"issue":"18","key":"4739_CR70","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.19.00370","volume":"37","author":"JE Tota","year":"2019","unstructured":"Tota\u00a0JE, Best\u00a0AF, Zumsteg\u00a0ZS et\u00a0al (2019) Evolution of the oropharynx cancer epidemic in the United States: moderation of increasing incidence in younger individuals and shift in the burden to older individuals. J\u00a0Clin Oncol 37(18):1538\u20131546","journal-title":"J Clin Oncol"},{"issue":"1","key":"4739_CR71","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1542\/peds.2014-3745","volume":"136","author":"P Van Damme","year":"2015","unstructured":"Van Damme\u00a0P, Olsson\u00a0SE, Block\u00a0S et al (2015) Immunogenicity and safety of a\u00a09-Valent HPV vaccine. Pediatrics 136(1):e28\u2013e39","journal-title":"Pediatrics"},{"issue":"35","key":"4739_CR72","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1016\/j.vaccine.2016.06.056","volume":"34","author":"P Van Damme","year":"2016","unstructured":"Van Damme\u00a0P, Meijer\u00a0CJ, Kieninger\u00a0D et al (2016) A phase III clinical study to compare the immunogenicity and safety of the 9\u2011valent and quadrivalent HPV vaccines in men. Vaccine 34(35):4205\u20134212","journal-title":"Vaccine"},{"issue":"33","key":"4739_CR73","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","volume":"67","author":"EA Van Dyne","year":"2018","unstructured":"Van Dyne\u00a0EA, Henley\u00a0SJ, Saraiya\u00a0M, Thomas\u00a0CC, Markowitz\u00a0LE, Benard\u00a0VB (2018) Trends in human papillomavirus-associated cancers\u2014United States, 1999\u20132015. MMWR Morb Mortal Wkly Rep 67(33):918\u2013924","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"4","key":"4739_CR74","first-page":"613","volume":"56","author":"H Wadstr\u00f6m","year":"2017","unstructured":"Wadstr\u00f6m\u00a0H, Arkema\u00a0EV, Sj\u00f6wall\u00a0C et\u00a0al (2017) Cervical neoplasia in systemic lupus erythematosus: a\u00a0nationwide study. Rheumatology 56(4):613\u2013619","journal-title":"Rheumatology"},{"issue":"6","key":"4739_CR75","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.vaccine.2019.12.017","volume":"38","author":"HS Whitworth","year":"2020","unstructured":"Whitworth\u00a0HS, Gallagher\u00a0KE, Howard\u00a0N et al (2020) Efficacy and immunogenicity of a\u00a0single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: a systematic review of evidence from clinical trials. Vaccine 38(6):1302\u20131314","journal-title":"Vaccine"},{"issue":"3","key":"4739_CR76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00105-017-3938-z","volume":"68","author":"U Wieland","year":"2017","unstructured":"Wieland\u00a0U, Kreuter\u00a0A (2017) Genital warts in HIV-infected individuals. Hautarzt 68(3):192\u2013198","journal-title":"Hautarzt"},{"key":"4739_CR77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2340\/00015555-1375","volume":"93","author":"A Wikstrom","year":"2013","unstructured":"Wikstrom\u00a0A, Vassilaki\u00a0I, Hedblad\u00a0MA et al (2013) The spectrum of genital human papillomavirus infection among men attending a\u00a0Swedish sexually-transmitted infections clinic: human papillomavirus typing and clinical presentation of histopathologically benign lesions. Acta Derm Venereol 93:223\u2013227","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"4739_CR78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/cid\/ciy274","volume":"67","author":"TJ Wilkin","year":"2018","unstructured":"Wilkin\u00a0TJ, Chen\u00a0H, Cespedes\u00a0MS et al (2018) A randomized, placebo-controlled trial of the quadrivalent human papillomavirus vaccine in human immunodeficiency virus-infected adults aged 27 years or older: aIDS clinical trials group protocol A5298. Clin Infect Dis 67(9):339\u20131346","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4739_CR79","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/1940-6207.CAPR-19-0098","volume":"12","author":"C Wittekindt","year":"2019","unstructured":"Wittekindt\u00a0C, Wagner\u00a0S, Bushnak\u00a0A et\u00a0al (2019) Increasing incidence rates of oropharyngeal squamous cell carcinoma in Germany and significance of disease burden attributed to human papillomavirus. Cancer Prev Res 12(6):375\u2013382","journal-title":"Cancer Prev Res"},{"issue":"11","key":"4739_CR80","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","volume":"378","author":"R Yarchoan","year":"2018","unstructured":"Yarchoan\u00a0R, Uldrick\u00a0TS (2018) HIV-associated cancers and related diseases. N\u00a0Engl J Med 378(11):1029\u20131041","journal-title":"N Engl J Med"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-020-04739-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T16:35:18Z","timestamp":1697387718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-020-04739-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4739"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04739-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,18]]},"assertion":[{"value":"26 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Wieland gibt an, dass kein Interessenkonflikt besteht. A.\u00a0Kreuter hat Referentenhonorare von MSD Sharp & Dohme GmbH erhalten und war im Advisory Board von MSD Sharp\u00a0& Dohme GmbH t\u00e4tig.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}